Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
RLMD similar filings
- 23 Mar 21 Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2020 Financial Results
- 15 Mar 21 Regulation FD Disclosure
- 15 Mar 21 Regulation FD Disclosure
- 7 Jan 21 Other Events
- 5 Jan 21 Departure of Directors or Certain Officers
- 14 Dec 20 Other Events
- 8 Dec 20 Relmada Therapeutics Announces Initiation of Phase 3 Program for REL-1017 as Adjunctive Treatment for Patients with Major Depressive Disorder
Filing view
External links